The attenuation of dyslipidemia by curcumin supplementation could in turn improve the glucose metabolic status of T2DM patients, and multiple molecular targets including PPAR-γ [32,33], cholesteryl ester transfer protein [42], and lipoprotein lipase [15] who contribute to the beneficial effects of curcumin. This evidence concerns the gene PPARG and type 2 diabetes mellitus.